Abstract
The study observed the effect on thrombus of the glycoprotein IIb/IIIa antagonist abciximab. We studied retrospectively 72 patients, who had definite or possible thrombus that was newly developed during cardiac intervention.
Recommended Citation
CHUAN-YU GAO, ROBERT WHITBOURN, Evaluation of Abciximab on Dissolution of Newly Formed Thrombus Developed During Coronary Angioplasty and Stenting Journal of the Hong Kong College of Cardiology 2022;8(3):138-144 https://doi.org/10.55503/2790-6744.1408
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
COinS
